Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy-Reference-Cited by-同舟云学术

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

Published:2019-10-14 Issue:3 Volume:71 Page:1023-1036
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mandorfer Mattias¹²³^ORCID,Kozbial Karin¹,Schwabl Philipp¹²,Chromy David¹²,Semmler Georg¹²,Stättermayer Albert F.¹²,Pinter Matthias¹²,Hernández‐Gea Virginia³⁴⁵,Fritzer‐Szekeres Monika⁶,Steindl‐Munda Petra¹,Trauner Michael¹,Peck‐Radosavljevic Markus¹²⁷,García‐Pagán Juan C.³⁴⁵^ORCID,Ferenci Peter¹^ORCID,Reiberger Thomas¹²^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine III Medical University of Vienna Vienna Austria

2. Vienna Hepatic Hemodynamic Lab Medical University of Vienna Vienna Austria

3. Barcelona Hepatic Hemodynamic Lab, Liver Unit Hospital Clínic Barcelona Spain

4. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

5. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) Madrid Spain

6. Department of Laboratory Medicine Medical University of Vienna Vienna Austria

7. Department of Internal Medicine and Gastroenterology (IMuG), Hepatology, Endocrinology, Rheumatology, and Nephrology with Centralized Emergency Service (ZAE) Klinikum Klagenfurt am Wörthersee Klagenfurt Austria

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30885

Reference48 articles.

1. Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease

2. Advances in the management of HIV/HCV coinfection

3. Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

4. HCV targeting of patients with cirrhosis

5. American Gastroenterological Association Institute Clinical Practice Update—Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis;JHEP Reports;2024-02

2. Predicting de‐novo portal vein thrombosis after HCV eradication: A long‐term competing risk analysis in the ongoing PITER cohort;United European Gastroenterology Journal;2023-11-30

3. Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents;Life;2023-09-05

4. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes;PLOS ONE;2023-08-24

5. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome;Hepatology International;2023-08-21